In tumors, G6PD levels increase with tumor grade and the enzyme is targeted by miR-206 [49] and miR-1 [50] in cervical cancers associated with papillomavirus infections, whereas it is downregulated by miR-1 in pituitary tumors [51]. Here, G6PD is linked to neoplasm.